Quell Therapeutics is a cell therapy company
Quell Therapeutics has raised $156.0M in total funding. The most recent round was Series B. The last funding was announced in November 2021.
Quell Therapeutics's investors include Janus Henderson Investors, Point72, Jeito Capital, SV Health Investors, Fidelity.
Quell Therapeutics is headquartered in London, United Kingdom.
Quell Therapeutics is a cell therapy company
Quell Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Quell Therapeutics — Funding & Investors." VCBacked, November 29, 2021, https://www.vcbacked.co/company/quell-therapeutics. Accessed November 12, 2026.
VCBacked. (2021). Quell Therapeutics — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/quell-therapeutics
{{cite web |title=Quell Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/quell-therapeutics |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Quell Therapeutics? Request a listing update